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Creating, Protecting, and Using Crop 
Biotechnologies Worldwide in an Era of Intellectual 
Property 
Philip G. Pardey, Bonwoo Koo and Carol Nottenburg* 
 
I.  INTRODUCTION 
Most crops are grown in places where they did not occur 
naturally, but were introduced there incidentally or 
intentionally.  The international development and 
dissemination of new and improved seed varieties have been 
the basis for productivity improvement in agriculture since 
crops were first domesticated about ten millennia ago.1  
Initially, the movement of plant material involved farmers 
carrying seed as they migrated to new areas.2  Columbus 
returned from his voyage to the New World in the latter part of 
the fifteenth century laden with new plants that ushered in an 
extended era of state-sponsored expeditions to gather and 
evaluate plant materials the world over.3  For most of that 
                                                 
 * Philip Pardey is Professor of Science and Technology Policy in the 
Department of Applied Economics, University of Minnesota.  Bonwoo Koo is a 
Research Fellow at the International Food Policy Research Institute, 
Washington D.C.  Carol Nottenburg is a Principal of Cougar Patent Law, 
formerly Chief Legal Officer and Director, Cambia IP Resource, CAMBIA, 
Canberra, Australia.  The authors thank Doug Ashton, Eduardo Castelo-
Magalhães, Barry Ryan, and Patricia Zambrano for their help in preparing 
this paper.  Brian Wright provided insightful comments for which we are 
especially grateful.  This paper is a revised and updated version of a paper 
first presented at the WIPO-UPOV Symposium on Intellectual Property 
Rights in Plant Biotechnology held on October 24, 2003 at the World 
Intellectual Property Organization (WIPO) and International Union for the 
Protection of New Varieties of Plants (UPOV) headquarters, Geneva. 
 1. See Philip Pardey & Brian Wright, Agricultural Research & 
Development, Productivity & Global Food Products, in PLANTS, GENES AND 
CROP BIOTECHNOLOGY (M.J. Chrispeels & D.E. Sadava, eds., 2d ed. 2003).  
 2. Id.  
 3. Id.   
  
214 MINN. J.L. SCI. & TECH. [Vol. 6:1 
 
time, new crop varieties were largely treated as common 
property, shared freely among farmers and countries and 
generating billions of dollars of benefits worldwide.4 
The era of free and unencumbered access to new crop 
varieties appears to be passing.  This has implications beyond 
the movement and marketing of new crop varieties; it affects 
their creation as well.  Scientific crop breeding, drawing on 
Mendelian Laws of Heredity, began in earnest about a century 
ago.5  For many countries, varietal innovations continued to 
rely heavily on introduced germplasm, and the international 
spillovers of germplasm, breeding techniques, and know-how 
continued to be integral to these crop improvement efforts.6  
While substantial germplasm flowed from poorer countries into 
the rich ones, enhanced germplasm also moved back to the 
poorer parts of the world.7  This reverse flow accelerated as the 
Green Revolution took hold, beginning in the 1960s, as 
developing-country farmers took up improved varieties in a big 
way and local breeding efforts screened and adapted these 
varietal spill-ins to better deal with local agroecological 
realities and production constraints.8 
Throughout all these changes, crop improvement has been, 
and largely remains, a cumulative or sequential innovation 
process—new varieties build directly on the selection and 
breeding efforts of farmers and scientists of yesteryear.  A new 
twist has come with the advent of modern biotechnology tools.  
Now the genetic makeup of new varieties are altered by the 
“conventional or classical” genetic manipulation techniques 
practiced formally by scientists for the past 100 years (and less 
formally by farmers for eons prior to that), or by bioengineered 
techniques involving the purposeful insertion of gene fragments 
into plants from other plants or other organisms using genomic 
and transformation technologies developed within the past two 
                                                 
 4. Sarah Boettiger, et al., Intellectual Property Rights for Plant 
Biotechnology: International Aspects, in HANDBOOK OF PLANT 
BIOTECHNOLOGY (P. Christou & H. Klee eds. 2004) 
 5. See PHILIP G. PARDEY & NIENKE M. BEINTEMA, SLOW MAGIC: 
AGRICULTURAL R&D A CENTURY AFTER MENDEL 3 (Int’l. Food Policy Research 
Inst. Food Policy Report, Oct. 2001). 
 6. See id. 
 7. See id. 
 8. See Robert Evenson & Douglas Gollin, Assessing the Impact of the 
Green Revolution, 1960 to 2000, 300 SCIENCE 758 (2003). 
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decades.9  Like the crop varieties themselves, the tools of crop 
manipulation are increasingly encumbered by intellectual 
property, making the future of crop-improvement inextricably 
tied to the future of the biotechnologies increasingly used to 
manipulate them. 
Whether these changing market, scientific, and intellectual 
property regimes will help or hinder efforts to develop and 
disseminate varietal technologies in the future, and especially 
the crop innovations required by the developing world, is an 
open question.  This paper surveys and reports newly compiled 
evidence on the research and, especially, the intellectual 
property landscapes regarding plant biotechnologies as a step 
toward resolving these questions. 
II.  CROP BIOTECHNOLOGY CREATION 
Crop biotechnologies are not necessarily used or protected 
where created.  The location and structure of the relevant 
research and development sectors are important as a basis for 
analyzing the patterns of intellectual property rights in the 
resulting crop innovations and their uptake worldwide. 
A.  RESEARCH SPENDING 
In 1995 about half a trillion U.S. dollars were invested in 
all public and privately financed science worldwide, of which 
eighty-five percent  could be attributed to rich countries.10  
Agricultural research accounted for thirty-three billion dollars, 
or nearly seven percent, of all private and public spending on 
                                                 
 9. All crops are genetically modified, making the mnemonic “GMOs” 
(genetically modified organisms) misleading in ways that seem to have 
profoundly affected peoples’ perceptions about the latest set of crop-
improvement techniques.  Among the continuum of genetic modification 
methods, it is useful to distinguish between classically bred crops using 
techniques like hybridization that became commonplace among scientific 
breeders beginning a century ago, and varieties whose DNA have been 
manipulated with bioengineering techniques like the ballistic gun or 
Agrobacterium-mediated transformations of DNA that form the forefront of 
present crop improvement methods.  Some modern varieties are 
conventionally bred but incorporate herbicide tolerant genes identified using 
modern genomic methods, confounding efforts to neatly classify crop varieties.  
For a more complete description of these technologies, see MAARTEN J. 
CHRISPEELS & DAVID E. SADAVA, PLANTS, GENES, AND CROP BIOTECHNOLOGY 
(2d ed. 2002). 
 10. See PARDEY & BEINTEMA, supra note 5, at 11 tbl.B4. 
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science.11 
The public share of agricultural investment was 
substantial, but is now flagging.  Worldwide, public 
investments in agricultural research nearly doubled in 
inflation-adjusted terms over the past two decades, from an 
estimated $11.8 billion in 1976 to nearly twenty-two billion 
dollars in 1995.12  Yet for many parts of the world, growth in 
spending during the 1990s slowed dramatically.  In the rich 
countries, public investment grew just 0.2 percent annually 
between 1991 and 1996 compared with 2.2 percent per year 
during the 1980s.13  In Africa, there was no growth at all.14  In 
Asia, the 4.4 percent annual growth figure compared with 7.5 
percent the previous decade.15 
The distribution of spending on agricultural research has 
shifted as well.  In the 1990s, for the first time, developing 
countries as a group spent more on public agricultural research 
than the developed countries.16  For example, a handful of rich 
countries accounted for $10.2 billion dollars in public 
spending.17  In 1995 the United States, Japan, France and 
Germany accounted for two-thirds of this public research, about 
the same as two decades before.18  Three developing 
countriesChina, India, and Brazilspent forty-four percent 
of the developing world’s public agricultural research money in 
1995, up from thirty-five percent in the mid-1970s.19 
As indicated in Table 1, by the mid-1990s about one-third 
of the thirty-three billion dollar total public and private 
agricultural research investment worldwide was private.20  But 
little of this research takes place in the developing world.  The 
overwhelming majority ($10.8 billion, or ninety-four percent, of 
the global total in 1995) is conducted in developed counties, 
                                                 
 11. Id. at 10. 
 12. Id. at 3. 
 13. Id. 
 14. Id. at 4 tbl.1. 
 15. See PARDEY & BEINTEMA, supra note 5, at 4 tbl.1. 
 16. Id. 
 17. Id. 
 18. Id. 
 19. Id. at 4. 
 20. Id. at 10. 
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where private research is over half of all expenditures.21  In 
developing countries, the private share of research is just five 
percent, and public funds are still the major source of support.22 
 
TABLE 1: PRIVATE AND PUBLIC AGRICULTURAL RESEARCH AND 
DEVELOPMENT INVESTMENTS, CIRCA 199524 
 
 Expenditures  Shares 
 Public Private Total  Public Private Total 
 (million 1993 international dollars)  (percent) 
Developing 
countries 
11,469 672 12,141  94.5 5.5 100 
Developed 
countries 
10,215 10,829 21,044  48.5 51.5 100 
        
Total 21,692 11,511 33,204  65.3 34.7 100 
 
Private agricultural research is displacing public research 
generally and specifically regarding the development of new 
varieties of crops that have high commercial value.25  This 
tendency is especially pronounced in countries like the United 
States where private agricultural research and development 
was ninety percent of public spending in 1960, growing to 133 
                                                 
 21. See PARDEY & BEINTEMA, supra note 5, at 10 tbl.2.  
 22. Id. 
 24. Id.  Drawing together estimates from various sources meant there 
were unavoidable discrepancies in what constitutes “private” and “public” 
research.  For example, the available data for Asia includes nonprofit producer 
organizations as part of private research, whereas Pardey and Beintema opted 
to include research done by nonprofit agencies as part of public research in 
Latin America and elsewhere when possible. 
 25. See id. at 12. 
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percent by 1996, the latest year for which comparable public-
private data are available.26  Private investments, fueled by 
agricultural biotechnology research, gravitate to techniques 
which promise large markets, are protected by intellectual 
property rights, and are easily transferable across 
agroecologies.  These included food processing and other post-
harvest technologies and chemical inputs including pesticides, 
herbicides and fertilizers.27  Hence, while private research is 
much more geographically concentrated than public research, 
many of its fruits may be more easily transferred across 
borders and agroecological zones.  Even so, private research is 
far less likely in products or methods with small markets, weak 
intellectual property protection, and limited transferability- 
precisely the situations in which most poor farmers are found. 
B.  RESEARCH INTENSITIES AND STOCKS OF KNOWLEDGE 
One way to gauge the commitment of agricultural research 
funds, public or private, is to compare them to national 
agricultural output, rather than measuring them in absolute 
terms.  This relative measure captures the intensity of 
investment in agricultural research as a percentage of 
agricultural gross domestic product (GDP), not just the amount 
of total research spending.28  In 1995 developed countries spent 
$5.43 on public and private agricultural research and 
development for every one hundred dollars of agricultural 
output, compared with just sixty-six cents per one hundred 
dollars of output for developing countries.29  The eightfold 
difference in total research intensities illustrates the size of the 
technological gap in agriculture between rich and poor 
countries.  Moreover, the situation is growing worse.  The 
difference in public research intensity ratios was 3.5−fold in the 
1970s, compared with 4.3−fold now.30  An even wider gap would 
have opened up if private spending was also factored in.31 
These trends may actually understate the scientific 
knowledge gap.  Science is a cumulative endeavor, with a 
                                                 
 26. See generally id. 
 27. See id. at 12.    
 28. See PARDEY & BEINTEMA, supra note 5, at 13. 
 29. See id. at 13-14. 
 30. See id.  
 31. See id. 
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snowball effect.  Innovations beget new ideas and further 
rounds of innovation or additions to the cumulative stock of 
knowledge.  The sequential and cumulative nature of scientific 
progress and knowledge is starkly illustrated by crop-
improvement.  It generally takes seven to ten years of breeding 
to develop a uniform, stable, and superior variety.32  But 
breeders of today build on a base of knowledge built up by 
breeders of yesteryear.33  The cumulative nature of this process 
means that past discoveries and related research are an 
integral part of contemporary agricultural innovations.  
Conversely, the loss of a variety, or the details of the breeding 
histories that brought it about, means the loss of accumulated 
past research to the present stock of knowledge.  “Providing 
adequate funding for research is thus only part of the science 
story.  Putting in place the policies and practices to accumulate 
innovations and increase and preserve the stock of knowledge 
is an equally important and almost universally unappreciated 
foundation.”34 
Estimates of the stocks of scientific knowledge arising from 
public and private research conducted in the United States and 
Sub-Saharan Africa have been developed by Philip G. Pardey 
and Nienke Beintema.35  In their report, Slow Magic, Pardey 
and Beintema compared historical research spending with the 
agricultural GDP for 1995.36  They examined historical 
research spending starting from 1850 for the United States and 
1900 for Africa and allowed for a gradual diminution of the 
                                                 
 32. See id. at 15.  
 33. See BONWOO KOO & BRIAN D. WRIGHT, ECONOMICS OF PATENTING A 
RESEARCH TOOL 3-5 (Int’l Food Policy Research Inst., Environment and 
Production Technology Division Discussion Paper No. 88, Jan. 2002), available 
at http://www.ifpri.org/. 
 34. PARDEY & BEINTEMA, supra note 5, at 15.  Discoveries and data that 
are improperly documented or inaccessible (and so effectively exist only in the 
minds of the relevant researchers) are lost from the historical record when 
researchers retire from science.  These “hidden” losses seem particularly 
prevalent in cash-strapped research agencies in the developing world, where 
inadequate and often irregular amounts of funding limit the functioning of 
libraries, data banks and gene banks, and hasten staff turnover.  There can 
also be catastrophic losses, tied to the political instability that is a root cause 
of hunger.  Civil strife and wars cause an exodus of scientific staff, or at least a 
flight from practicing science.  Id. 
 35. Id. at 15-17. 
 36. See id. at 17. 
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effect of distant past research and development spending on 
money measures of the current stock of knowledge.37  They 
found that the accumulated stock of knowledge in the United 
States was about eleven times more than the amount of 
agricultural output produced in that year.38  In other words, for 
every $100 of agricultural output there existed a $1,100 stock of 
knowledge to draw upon.39  In Africa, the stock of knowledge in 
1995 was actually less than the value of African agricultural 
output.40  The ratio of the U.S. knowledge stock relative to U.S. 
agricultural output in 1995 was nearly twelve times higher 
than the corresponding amount for Africa.41  Stocks of 
knowledge measures provide a better basis for evaluating the 
developed versus developing country’s capacity for actually 
carrying out crop biotechnologies.  In fact, the overall 
differences may understate the effective gaps for this advanced 
area of agricultural research and development.  These gaps also 
underscore the immensity, if not the outright impossibility, of 
playing “catch-up,” in addition to the need to transfer 
knowledge across borders and continents. 
C.  BIOTECHNOLOGY TRIALS 
Absent meaningful data on “crop-related biotechnology 
research” spending, the only indication of the location of crop 
biotechnology research are data on the number of field trials 
conducted internationally.42  “Crop-related biotechnology 
research” can be difficult to define.  “Biotechnology” can run the 
whole gambit from conventional breeding through cultivating 
methods to genomic and bioengineering techniques.  In 
addition, many biotechnology techniques developed with 
spending directed to the health sciences have agricultural 
applications as well.  Focusing their search solely on crop-
related biotechnology research, Pardey and Beintema compiled 
data on the number of field trials conducted on bioengineered 
crops from 1987 through December 2000 grouped by the 
                                                 
 37.  See id. at 15-17.   
 38. Id. at 17. 
 39. Id. 
 40. PARDEY & BEINTEMA, supra note 5, at 17 
 41. Id. 
 42. See id. at 18. 
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regions in the world where the trials were conducted.43  These 
data, which are summarized in Table 2, indicates that a total of 
twenty-seven countries conducted trials on fourteen different 
crops and 183 different “events,” each event involving the 
insertion of a specific gene in a particular crop, resulting in the 
expression of a trait in that crop.  For example, insertion of the 
Bt cry1(c) gene into a particular cotton variety is considered an 
event. 
                                                 
 43. See id. at 18.  As indicators of the level of bioengineering research 
effort, these data must be taken with a grain of salt.  To meaningfully assess 
the distribution of transgenic crops being tested in the ground, one would like 
the notion of “field trial” to be standardized across countries.   One option is to 
count each location as a separate instance, but in the United States a 
“location” can have many sites.  For example, test 01-024-26n in the APHIS 
database contains Pennsylvania as one location, but there are 313 sites 
comprising a total of 1,838 acres.  See id.  Likewise, Canada lists field trials 
conducted at multiple sites within a province as one field trial, but it is not 
clear if all the data for all the other countries are reported similarly.  See id. 
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TABLE 2: FIELD TRIALS OF BIOENGINEERED CROPS BY REGIONS 
OF THE WORLD44 
 
      Number of Approved   Field Trials 
   Events/crops   Number of  Share of  
            
          Global 
Private  
in-country 
      Countries Events45 Crops   Countries Trials   total total 
          (percentage) 
Developed  
Countries 19 160 14  20 9,701  84.2 na 
 United States  1 49 14  1 6,337  55 83.4 
 Canada  1 49 4  1 1,233  10.7 63.9 
 All others  17 62 5  18 2,131  18.5 na 
            
Developing  
Countries 8 23 4  19 1,822  15.8 na 
 Argentina  1 7 3  1 393  3.4 90.1 
 China  1 5 4  1 45  0.4 na 
 All others  6 11 3  17 1,384  12 na 
            
Total   27 183 14   39 11,523   100 na 
 
Eighty-four percent of the world’s trials were conducted in 
rich countries.46  Two-thirds of that total was in the United 
States and Canada alone.47  This points to a biotechnology 
research gap between rich and poor countries that is even more 
pronounced than the gap in overall agricultural research and 
development spending in which sixty-four percent of global 
agricultural research and development was conducted in rich 
                                                 
 44. Id. at 18.  The notation “na” designates that the information is not 
available.  The data is through December of 2000 where available.  For the 
United States and Canada, and perhaps other countries, a single “trial” may 
consist of tests at different sites.   
 45. Data through to December 2000 where available. 
 46. See id.  
 47. See PARDEY & BEINTEMA, supra note 5, at 10 tbl.2. 
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counties.48  Two fundamental factors may account for much of 
the marked spatial asymmetry in agricultural biotechnology 
research: who conducts the research and the nature of the 
science itself.  First, as indicated in Table 2, the preponderance 
of these biotechnology trials are conducted by private firms and 
most of the world’s private agricultural research and 
development takes place in rich counties.  Second, this type of 
cutting-edge research requires access to highly skilled 
scientists; well-functioning scientific infrastructure that 
provides ready access to reagents and a myriad of laboratory 
equipment and supplies, and technical information; and the 
appropriately trained support staff to help carry out the 
research.  Even though most of the trials are conducted by 
private firms, the sophistication of the research involved and 
its pace of change mean that “applied” aspects of the 
biosciences are likely to receive significant spillovers from on-
going basic research and from accumulated stocks of scientific 
knowledge arising from past research.  Both of these elements 
are much more readily supplied in rich rather than poor 
countries.  Indeed, it is the localized spillovers from university 
research often involving tacit knowledge embodied in the 
scientific and technically trained people of university 
communities that influence the location of industrialized 
research and development.49 
III.  AN ECONOMIC PRIMER ON INTELLECTUAL 
PROPERTY RIGHTS 
Research and development, like almost all other aspects of 
life, is an economic activity.  As a consequence, who pays for or 
performs the research, where it is performed, and who gains 
and loses are all influenced by economic incentives.  The degree 
to which innovators can appropriate the fruits of their 
endeavors lies at the heart of the incentives to invest, giving 
rise to pervasive policies worldwide to assign property rights to 
innovations in an effort to better align private incentives with 
                                                 
 48. See id. 
 49. See JAMES D. ADAMS, COMPARATIVE LOCALIZATION OF ACADEMIC AND 
INDUSTRIAL SPILLOVERS 2 (Nat’l Bureau of Econ. Research Working Paper No. 
8292, May 2001), available at http://www.nber.org/papers/w8292; see also 
Gregory D. Graff, et al., Agricultural Biotechnology's Complementary 
Intellectual Assets. 85 REV. OF ECON. AND STAT. 349 (2003). 
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social interests. 
The conventional rationale for protecting intellectual 
property by patents or other means is to provide some 
proprietary or “monopoly” rights to an invention—albeit 
circumscribed and exclusionary in nature—in exchange for 
public disclosure of the details of the invention.50  The 
information that is disclosed may be useful for further 
innovation by others.  However, the monopoly right also 
encourages invention directly, and the social value of the right 
tends to include surplus above the private value.  Thus, the 
private and social benefits of patents include wide diffusion of 
the creation of aspects of new or advanced technologies.  The 
costs are transitory, that is for the life of a patent, and entail 
higher-than-otherwise prices or constrained choices of 
innovations subject to some monopolistic behavior.  However, 
this conventional, static, one-off view of invention does not fully 
reflect the dynamic nature of a large part of research and 
development. 
Much technological change comes in the form of cumulative 
innovation processes, whereby the fruits of innovation 
frequently materialize as the embodiment of a sequence of prior 
innovations.  While strong patent protection may stimulate the 
earlier-than-otherwise development of a research tool, it can 
also delay or deter follow-on innovation due to the transaction 
costs of negotiating a license or merger and the ability to 
prevent competitors from introducing similar technology.51  
Thus the dynamic cost of a patent within a cumulative 
innovation scheme—which includes the accumulated costs of 
delayed follow-on inventions—is an important policy 
consideration that is often neglected when counting the 
conventional or static social cost of a patent.52 
A special case of cumulative innovation involves the 
development of a research tool, that is a product or process 
                                                 
 50. WILLIAM D. NORDHAUS, INVENTION, GROWTH AND WELFARE: A 
THEORETICAL TREATMENT OF TECHNOLOGICAL CHANGE 3-4 (M.I.T. Press, 
1969). 
 51. See Robert P. Merges & Richard R. Nelson, On the Complex Economics 
of Patent Scope, 90 COLUM. L. REV. 839, 874-75 (1990); Michael A. Heller & 
Rebecca S. Eisenberg, Can Patents Deter Innovation? The Anticommons in 
Biomedical Research, 280 SCIENCE 698 (1998). 
 52. See KOO & WRIGHT, supra note 33, at 3-5. 
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whose only value is as an input to follow-on innovations.  In 
agricultural biotechnology, a research tool can be a patent on a 
DNA sequence modified to enhance the expression of a trait 
such as insect-resistance, while the follow-on innovation may 
be a new transgenic variety of cotton.  Since the patentee of a 
research tool can capture revenue only through direct 
production of the follow-on innovations, efficient compensation 
of the patentee, through licensing, joint ventures, or other 
means, is critical in providing the incentive to innovate 
research tools.  In addition, these efficient mechanisms also 
reduce the transaction costs incurred by those contracting for 
use of the rights, thereby encouraging the utilization of 
research tools by follow-on innovators. 
One way of reducing dynamic costs and encouraging 
technology transactions is to clarify property rights.  The Bayh-
Dole Act of 1980 and subsequent legislation, which allowed 
U.S. universities, other non-profit institutions, and government 
labs to patent and exclusively license federally funded 
inventions, was intended to achieve this purpose.53  Firms are 
often unwilling to invest significantly in developing and 
disseminating innovations lacking clearly defined property 
rights.  This point was clearly captured by the 1945 Report of 
the U.S. House of Representatives, which stated that “what is 
available for exploitation by everyone is undertaken by no 
one.”54  The main objective of the Bayh-Dole Act is to foster 
markets for the transfer of technology, and there is some 
evidence the Act has achieved these aims.55  However, the 
Bayh-Dole Act is most effective when inventions require heavy 
expenditure in downstream technology and product 
development, which is not the case for all technologies.  In 
addition, some have argued that the Act may actually constrain 
and delay the flow of fundamental scientific knowledge as 
“prior art” concerns impede open scientific discourse through 
seminars and the professional literature.56  This could shift the 
                                                 
 53. See 35 U.S.C. §§ 200-212 (2000). 
 54. Adam B. Jaffe, The U.S. Patent System in Transition: Policy 
Innovation and the Innovation Process, 29 RES. POL’Y. 531, 534 (2000), quoting 
H.R. DOC. NO. 22, at 5 (1945).   
 55. See Richard Jensen & Marie Thursby, Proofs and Prototypes for Sale: 
The Licensing of University Inventions, 91 AM. ECON. REV. 240, 241 (2001). 
 56.  See, e.g., Roberto Mazzoleni & Richard R. Nelson, The Benefits and 
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emphasis of university research from fundamental basic 
research toward more applied research that is potentially more 
rewarding financially for the university or its research faculty, 
but not necessarily for society as a whole over the long run.57 
The impact of a patent system also depends on the type of 
technology itself.  Agriculture seeds have special attributes, 
most significantly their almost costless reproducible nature, 
that merit special attention.  Under plant variety protection 
schemes, farmers may legally save, reuse, and sometimes sell 
seeds in following seasons so that seed firms are faced with 
only the residual demand for their seeds in subsequent seasons.  
This problem, together with the difficulty of monitoring and 
enforcing property rights to seed, makes its legal protection less 
valuable than other forms of protection on other products.  
Private seed markets have responded to the appropriability 
problem by developing hybrid varieties or pursuing genetic use 
restriction technologies (GURTs).  These methods prevent 
seeds from effectively reproducing and serve as a form of 
“biological” rather than legal property protection.58 
What evidence is there that intellectual property rights 
stimulate inventive activity?  Although there are no readily 
measurable markets for intellectual property rights in which 
the benefits and costs of patents, for example, can be easily 
evaluated, a few studies have sought to measure the overall 
inventive effects of patents.  Findings from survey studies 
suggest that, with the exception or pharmaceuticals, innovators 
rely primarily on other means such as trade secrets or first-
mover advantages rather than patent protection to appropriate 
the returns from their innovative investment.59  Some have 
estimated the private value of patent protection using patent 
data and concluded that the distribution of patent-rights values 
                                                 
Costs of Strong Patent Protection: A Contribution to the Current Debate, 27 
RES. POL’Y 273 (1998). 
 57. Mazzoleni & Nelson, supra note 56, at 275-86.   
 58. Convention on Biological Diversity, Consequences of the Use of the 
New Technology for the Control of Plant Gene Expression for the Conservation 
and Sustainable Use of Biological Diversity (June 1999), available at 
http://www.biodiv.org/doc/meetings/sbstta/sbstta-04/official/sbstta-04-09-rev1-
en.doc. 
 59. See Richard C. Levin et al., Appropriating the Returns from Industrial 
Research and Development, 1987 BROOKINGS PAPERS ON ECON. ACTIVITY 783, 
796 (1987). 
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is sharply skewed with most of the value concentrated in a 
small number of patents.60  Using European patent renewal 
data, Mark Schankerman estimated that the private value of 
patent protection was about fifteen to twenty-five percent of the 
related research and development expenditure, suggesting a 
small impact of patent rights on innovative behavior.61 
Most empirical studies, all using U.S. data, have generally 
found weak or indeterminate empirical evidence to suggest that 
plant breeders’ rights are effective in stimulating investments 
in varietal-improvement research.62  Some point out that plant 
variety protection does not provide patent-like ex ante 
investment incentives, nor generate substantial ex post 
licensing and enforcement activity.63  Julian Alston and 
Raymond Venner found that varietal rights for wheat in the 
United States had little measurable impact on the rate of 
technical change in that crop and may simply have served as a 
marketing tool.64 
Given evidence of the general lack of appropriability from 
patent or plant variety protection, why do innovators continue 
to apply for intellectual property protection?  Even accepting 
the claim that practicing patents may not be the primary 
means by which large firms recoup their research and 
development investments, it can still be an important incentive 
                                                 
 60. See Jean O. Lanjouw et al., How to Count Patents and Value 
Intellectual Property: The Uses of Patent Renewal and Application Data, 46 J. 
INDUS. ECON. 405, 410 (1998). 
 61. See Mark Schankerman, How Valuable is Patent Protection?  
Estimates by Technology Field, 29 RAND J. ECON. 77, 79 (1998) (noting that 
although patent protection provides a substantial incentive to research and 
development, it does not appear to be the major source of private returns on 
inventive activity). 
 62. See, e.g., Richard K. Perrin et. al., Some Effects of the US Plant 
Variety Act of 1970. (N.C. State Univ., Econ. Research Rep’t 46, 1983); Mary K. 
Knudson and Carl E. Pray, Plant Variety Protection, Private Funding, and 
Public Sector Research Priorities, 73 AM. J. AGRIC. ECON. 882 (1991); Julian 
M. Alston & Raymond J. Venner, The Effects of the US Plant Variety 
Protection Act on Wheat Genetic Improvement, 31 RES. POL’Y 527 (2002). 
 63. Mark D. Janis & Jay P. Kesan, U.S. Plant Variety Protection: Sound 
and Fury…?, 39 HOUS. L. REV. 727, 776-77 (2002). 
 64. JULIAN M. ALSTON & RAYMOND J. VENNER, THE EFFECTS OF THE US 
PLANT VARIETY PROTECTION ACT ON WHEAT GENETIC IMPROVEMENT 31 (Int’l 
Food Policy Research Inst., Environment and Production Technology Division 
Discussion Paper No. 62, May 2000), available at 
http://www.grain.org/docs/eptdp62.pdf.  
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mechanism for smaller new entrants and the venture capital 
firms that often fund them.  Patent portfolios may be critical to 
obtaining venture capital or maintaining control of the 
technology while downstream innovation is pursued or 
production and sales capabilities are established.65  In addition, 
both large and small firms use patents to block products of 
their competitors and as bargaining chips when negotiating 
cross-licensing agreements, as is the case of the semiconductor 
industry.66  Strategic patenting behavior that relies on larger 
patent portfolios is consistent with rising rates of patenting and 
high patent-to-research and development spending ratios, even 
absent any perceived increase in the appropriable value of 
patents.67  For some developing countries with newly 
introduced plant variety rights such as China, a surge in plant 
variety protection applications may be explained by an over-
optimistic view of the prospective value of varietal rights even 
though the current size of the seed market and the cost and 
effectiveness of protection do not seem to economically justify 
the extent of protection presently being sought.68 
IV.  CROP BIOTECHNOLOGIES AS PROPERTY 
Creating new crop biotechnologies is one thing; protecting 
the intellectual property embodied in them is a related but 
separate undertaking, with its own set of economic costs and 
benefits.  Notwithstanding the incentive-to-innovate argument 
broached in the previous section, one view is that intellectual 
property rights over plant biotechnologies in rich and poor 
countries lead to a lock-out phenomenon, that is, the growth in 
intellectual property is restricting access to proprietary 
research results in ways that curtail the freedom to operate for 
research conducted in or on behalf of poor countries to the 
                                                 
 65. See Edmund W. Kitch, The Nature and Function of the Patent System, 
20 J.L. & ECON. 265, 275-80 (1977); Mazzoleni & Nelson, supra note 56, at 
276-80.  
 66. See Bronwyn H. Hall & Rosemarie Ham Ziedonis, The Patent Paradox 
Revisited: An Empirical Study of Patenting in the U.S. Semiconductor 
Industry, 1979-1995, 32 RAND J. ECON. 101, 108-11 (2001). 
 67. See id. 
 68. BONWOO KOO ET AL., THE ECONOMICS OF GENERATING AND 
MAINTAINING PLANT VARIETY RIGHTS IN CHINA 26 (Int’l Food Policy Research. 
Inst., Environment and Production Technology Division Discussion Paper No. 
100, February 2003), available at http://www.ifpri.org/.  
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detriment of developing-country food-security prospects.  This 
view is commonly held, even in the absence of evidence on the 
international pattern of intellectual property protection, a clear 
understanding of the effect this has on the rate and direction of 
inventive activity, the use to which these inventions are put, 
and the trade in agricultural products arising from this 
research.  What follows is a first pass at describing the 
intellectual property rights evidence for plant biotechnologies 
internationally. 
A.  PLANT VARIETY PROTECTION 
1.  Global trends 
Plant breeders’ rights have been available in many rich 
countries for at least the past three decades.  Germany, for 
example, has issued plant breeders’ rights since at least the 
1950s and likewise for a few other European countries.  The 
United States began issuing plant variety protection 
certificates (PVPCs) in 1971 for sexually reproduced plants.69  
Asexually reproduced plants such as grape vines, fruit trees, 
strawberries, and ornamentals that are propagated through 
cuttings and graftings have had recourse to intellectual 
property protection in the United States since 1930 when the 
Plant Patent Act was passed.70  Many middle-income countries 
passed plant variety protection legislation during the 1990s in 
compliance with their sui generis obligations to offer the 
intellectual property rights over plant varieties enshrined in 
Article 27.3(b) of the 1995 Trade-Related Aspects of Intellectual 
Property (TRIPS) agreement in the World Trade Organization 
(WTO).71   
Table 3 shows the pattern of applications for plant 
breeders’ rights since 1971 for thirty-seven countries grouped 
into four classes based on per capita income.72  As indicated, 
                                                 
 69.  See Janis & Kesan, supra note 63 at 739-40.  
 70. 35 U.S.C. §§ 161-164 (2000). 
 71.  See Biswajit Dhar, SUI GENERIS SYSTEMS FOR PLANT VARIETY 
PROTECTION OPTIONS UNDER TRIPS,  available at 
http://www.geneva.quno.info/pdf/sgco11.pdf.  
 72. See International Convention for the Protection of New Varieties of 
Plants, Dec. 2 1961, as amended on Mar. 19, 1991 (listing the states party to 
the convention as of Oct. 24, 2002), available at 
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nearly 138,000 plant breeders’ rights applications have been 
lodged worldwide since 1971.  Some applications were lodged 
before 1970, but the number is small (less than three percent) 
when compared with the totals reported in Table 3.  During the 
1970s and 1980s, rich countries accounted for ninety-two to 
ninety-six percent of the total applications.  Their share 
throughout the 1990s declined to average approximately 
seventy-five percent in 2001-02.  Plant breeders’ rights 
applications filed in upper middle-income countries such as 
Argentina, Chile, Czech Republic, Hungary, Poland, Slovakia, 
South Africa, and Uruguay grew steadily since the early 1970s, 
while reported plant breeders’ rights applications in lower 
middle-income countries that now includes Brazil, Bulgaria, 
China, Colombia, Romania, the Russian Republic, and Ukraine 
began increasing a decade later. 
                                                 
http://www.upov.int/en/publications/gazette/pdf/pub422_24-10-02.pdf (last 
visited Nov. 15, 2004).  At its inception in 1961, UPOV included five member 
countries: Belgium, France, Germany, Italy, and Netherlands – all high-
income countries.  By the end of 1992, there were twenty member countries; 
by September 2003, there were fifty-three member countries, of which twenty-
one were high-income, twenty-seven were middle-income, and five were low-
income countries.  Id.  Notably, under the TRIPs agreement, the “least 
developed” countries as defined by WTO are exempt from complying with 
Article 27.3(b) until 2005. See Patrick Mulvany, TRIPs, Biodiversity and 
Commonwealth Countries: Capacity Building Priorities for the 1999 review of 
TRIPs Article 27.3 (b), at http://www.ukabc.org/TRIPs/trips99.pdf (last visited 
Nov. 11 2004). 
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TABLE 3: PLANT BREEDERS RIGHTS APPLICATIONS—COUNTRIES 
GROUPED BY PER CAPITA INCOME, 1971-200273 
                                                 
 73. International Convention for the Protection of New Varieties of 
Plants, Union for the Protection of Plant Varieties Plant Variety Database CD 
2003b (on file with author);  KOO ET AL. supra note 68; KOO ET AL., 
PROTECTING AND LICENSING BIOLOGICAL INNOVATIONS: CROP RELATED 
RESEARCH IN BRAZIL (Int’l. Food Policy Research Inst., Environment and 
Production Technology Discussion Paper, forthcoming); US Plant Variety 
Office, Public Database, [hereinafter UPOV Database], at 
http://www.ams.usda.gov/science/PVPO/CertificatesDB.htm.  Bracketed 
numbers indicate number of countries in each income class.  Countries are 
classified into income classes according to World Bank criteria. Countries with 
2003 per capita gross national incomes greater than $9,386 are designated 
high income; $3,036-9,385 are upper-middle income; $766-3,035 are lower-
middle income; and less than $765 are low income. 
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The shifting geographical pattern of plant varietal 
protection arises for several reasons.  The growth in the total 
number of applications is largely due to an increase in the rate 
of applications per country per year.  Most high-income 
countries had plant breeders’ rights legislation in place for 
most of the period reported here, while in middle-income 
countries there was a rapid growth in the number of countries 
offering plant breeders’ rights, for example, two countries in 
1971, five in 1985, eight in 1990 and fifteen in 2002.  Increasing 
rates of protection may reflect legal, economic, and institutional 
factors.  One would expect applications to increase over time as 
awareness of the existence and effectiveness of plant breeders’ 
rights in a particular country increases and as the economic 
costs of applying for and evaluating applications decline with 
improved bureaucratic procedures.74 
Notably, the number of plant breeders’ rights sought in 
low-income countries is negligible - only twenty-three 
applications from Kyrgyzstan.75  The principal proximate cause 
of this situation is the lack of rights on offer in poor-countries.  
More fundamentally, it reflects a range of economic influences 
regarding the costs and benefits of securing breeders’ rights in 
a particular jurisdiction. 
To capture this cost-benefit calculus, Koo et al. use an 
option value model to characterize the crop breeders’ decision to 
apply for and retain varietal protection.76  While the costs of 
gaining and securing plant variety protection are known with 
reasonable surety, the sequence of future returns from a 
varietal right is highly uncertain for many reasons.77  There are 
uncertainties about the size of the appropriable seed market for 
a given crop, the probability of commercial success of the 
protected variety, and the extent of enforcement of assigned 
property rights.78  Where required, breeders make periodic, 
                                                 
74. Some countries have expanded the scope of crops eligible for 
protection overtime.  In China, for instance, a total of ten species were eligible 
for protection in September 1999, growing to thirty species by March 2002 
(including five major cereals, two oil crops, two roots and tubers, ten 
vegetables and fruits and eleven flowers and grasses but excluding cotton).  
KOO ET AL., supra note 68, at 19 n.32. 
75 UPOV Database, supra note 73. 
76 KOO ET AL., supra note 68, at 3-6. 
 77 See generally KOO ET AL., supra note 68.  
 78 See generally id.  
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often annual, renewal decisions preserving the right to pay 
renewal fees and exercise their exclusionary rights in future 
periods.79  Applying for, and subsequently renewing, plant 
variety protection rights thereby allows breeders to reserve the 
rights to potential future revenues, even if revenues in the 
short term are negligible.  Thus, the expected value of holding 
plant variety rights consists of the current returns captured 
from the coming year and the option to renew the right in the 
subsequent year. 
2.  Foreign Plant Varietal Rights Applications 
 
The UPOV data on varietal rights applications, shown in 
Table 4, allow us to distinguish between domestic and foreign 
applicants.  Overall, approximately thirty-four percent (17,529 
of a total of 51,258) of the applications filed in fifty UPOV 
member countries during 1998–2002 were lodged by foreigners.  
This substantial fraction of foreign applications indicates 
extensive potential spillovers of varietal improvement research 
done in one locale on seed market and production developments 
elsewhere in the world.  The intensity of foreign participation in 
domestic varietal rights markets differs markedly.  Looking 
regionally, the fraction of the applications lodged by foreigners 
was approximately thirty-one percent in high-income countries, 
sixty-five percent in upper middle-income countries, twenty-
five percent in lower-middle income countries, and thirty-nine 
percent in low-income countries.  The country-by-country 
participation of foreigners is even more variable.  For example, 
the share of foreign applications is eighty-five percent in 
Switzerland and Canada, forty-two percent in the United 
States, thirty-seven percent in the United Kingdom, twenty-
four percent in Japan, sixteen percent in the Netherlands and 
Germany, and eleven percent in France.80 
 
 
 
                                                 
 79 See generally id.  
 80. Int’l Union for the Protection of New Varieties of Plants, Plant Variety 
Protection Statistics for the Period 1998-2002 (2003), at 
http://www.upov.int/en/documents/c/37/c_37_7.pdf (last visited Nov. 11, 2004). 
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TABLE 4: SHARE OF PLANT BREEDER RIGHTS APPLICATIONS 
LODGED BY FOREIGNERS, 1998-200281 
 
Economies Total Residents Non-residents 
 (number of applications) 
High income economies (23) 39,079 26,893 12,186 
Upper middle income economies 
(11) 5,583 1,945 3,638 
Lower middle income economies 
(12) 6,109 4,592 1,517 
Low income economies (4) 487 299 188 
Total (50) 51,258 33,729 17,529 
 
3.  European and United States Trends. 
Worldwide, seed sales are estimated to be $30 billion 
annually.82  While the economic value of seed markets within 
the European Union, which is about $5.2 billion in total, is a 
little less than U.S. seed sales, that is, about $5.2 billion 
compared to $5.7 billion, respectively, Table 5 indicates that 
since 1971, there are three times more PBR applications in 
Europe than related applications in the United States.  Much of 
the difference may stem from multiple applications for the 
same variety among national jurisdictions in Europe, whereas 
only one application is required per variety in the United 
States.83  Part of the difference may arise from the different 
forms of varietal protection offered in Europe (plant breeders’ 
rights) versus the United States (plant patents, plant variety 
protection certificates, and utility patents).  About five percent 
of all the plant breeders and related patent applications in the 
                                                 
 81. Id.  See tbl.3 for country income classification criteria.  Bracketed 
figures indicate number of countries included in the data. 
 82. Int’l Seed Federation, Estimated Size of the Internal Market for seed 
and Other Planting Material of Selected Countries, at 
http://www.worldseed.org/statistics.html (last visited Oct. 30, 2004). 
 83. The information needed to create these data is publicly available, but 
requires compiling the plant breeder’s rights data by scrutinizing each 
individual varietal protection certificate for the first forty years the rights 
were on offer in the United States 
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United States are for utility patents, of which fifty-five percent 
pertain to corn and forty percent to soybeans.84 
                                                 
 84. See UPOV Database, supra note 73.  The utility patent data represent 
a preliminary tabulation by the authors based on patent-by-patent scrutiny of 
4,080 patents from 1972-2003 assigned USPTO patent code 800 to identify 
patents with claims that encompass plant varieties.   
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TABLE 5: PLANT-RELATED INTELLECTUAL PROPERTY 
APPLICATIONS IN THE EUROPEAN UNION AND THE UNITED 
STATES85 
                                                 
 85. Compiled from commissioned data obtained from the United States 
Patent and Trademark Office, Office of Electronic Information Products for US 
plant and utility patents; the US Plant Variety Protection Office’s public 
access database for the US plant variety protection; and UPOV Database and 
Community Plant Variety Office (CPVO) for data of European Union countries 
and CPVO series respectively. 
a. European Union aggregate includes applications for plant breeders’ 
rights in thirteen European countries.  U.S. aggregate includes plant and 
utility patents granted and plant variety protection certificate applications. 
b. CPVO members currently include Austria, Belgium, Denmark, Finland, 
France, Germany, Greece, Ireland, Italy, Luxembourg, Netherlands, Portugal, 
Spain, Sweden, and the United Kingdom.  Individuals or companies from 
member states of UPOV, but not a member of the European Union, can also 
apply, provided that an agent domiciled in the Community has been 
nominated.  Since it was first implemented in 1995, around thirty-five percent 
of these applications are lodged from the Netherlands, sixteen percent from 
Germany, fourteen percent from France, nineteen percent from elsewhere in 
the European Union and sixteen percent from outside the European Union. 
c. Preliminary tabulation by authors based on patent-by-patent scrutiny 
of the U.S. patent database to identify patents with claims that encompass 
plant varieties. 
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Four countries, the Netherlands, France, Germany and the 
United Kingdom, account for most of the European 
applications.  Adding applications lodged with the Community 
Plant Variety Office (CPVO) to those filed nationally, the 
Netherlands accounted for thirty-five percent of the European 
total, France twenty-two percent, Germany sixteen percent and 
the United Kingdom eight percent.86  The number of plant 
breeders’ rights applications filed with the CPVO has increased 
over time, offsetting declines in the number of applications 
lodged with national protection offices.  In 1996, there were 
1,385 applications lodged with the CPVO and a total of 2,766 
applications made to individual national systems.  By 2000, 
almost equal numbers of plant breeders’ rights claims were 
filed with the CPVO and the respective national offices (about 
2,000 applications each), and in 2001 CPVO applications 
(2,158) exceeded those filed with national offices (1,864).87 
Regarding the types of crops for which varietal protection 
is sought, ornamental crops account for more than half the 
total applications in both the United States and Europe.88  In 
the United States, cereal crops such as wheat and corn; oil and 
fibers; and fruit crops have each made up more than ten 
percent of the total number of applications since 1970.89  
Ornamentals and fruits are mostly protected by plant patents, 
while cereal, oil and fiber crops, and vegetables are usually 
                                                 
 86. Prior to April 27, 1995 when the CPVO was established, a breeder 
seeking protection for a variety throughout the European Union was required 
to submit an application to each of the member states.  Now with a single 
application to the CPVO, a breeder can be granted varietal protection rights 
throughout the European Union.  This European-wide system—CPVO 
members currently include Austria, Belgium, Denmark, Finland, France, 
Germany, Greece, Ireland, Italy, Luxembourg, Netherlands, Portugal, Spain, 
Sweden, and the exploit both a community plant variety right (CPVR) and a 
national plant breeders’ right in relation to that variety.  Individuals or 
companies from member states of UPOV, but not a member of the European 
Union, can also apply, provided that an agent domiciled in the Community has 
been nominated. The duration of CPVR protection is twenty-five years for 
most crops, and thirty years for potato, vine, and tree varieties.  See 
COMMUNITY PLANT VARIETY OFFICE, 2002 ANNUAL REPORT 11-12 (2003). 
 87. UPOV Database, supra note 73. 
 88. See Bonwoo Koo, et al., Plants & Intellectual Property: An 
International Appraisal, 305 SCIENCE 1295-97 (2004).   
 89. Id.  
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protected by plant variety rights.90  In Europe, cereals account 
for more than a quarter of the total PBR applications, followed 
by vegetable (ten percent), oil and fiber crop (five percent) and 
fruit (five percent).91 
B.  BIOTECHNOLOGY PATENTING PATTERNS 
An initial foray into examining the international 
dimensions of patent activity in biotechnology and specific 
sectors, such as agriculture and health, is presented in Figure 
1.  Numbers of patent applications submitted to the World 
Intellectual Property Organization (WIPO) under the Patent 
Cooperation Treaty (PCT) (Panel a) and patents granted by the 
European Patent Office (EPO) (Panel b) are plotted against the 
year published.  For this analysis, patent documents were 
selected on the basis of the International Patent Classification 
(IPC) scheme used by the patent offices.  Data were obtained 
for documents satisfying criteria for “biotechnology” and 
further sub-divided into “agricultural biotechnology” and 
“health biotechnology.”  For this work, “biotechnology” refers to 
“[t]he application of [s]cience and [t]echnology to living 
organisms as well as parts, products and models thereof, to 
alter living or non-living materials for the production of 
knowledge, goods and services”, a definition used by the 
Organisation for Economic Co-operation and Development.92  
While initially agricultural biotechnology patent documents 
exceeded health related documents both at EPO and WIPO, the 
situation reversed in 1999.  Furthermore, the spectacular rise 
in patent filings in the late 1980s and through the 1990s 
appears to be leveling off. 
                                                 
 90. Id.  
 91. Id.  
 92. Organization for Economic Co-operation and Development, Scientific, 
Industrial and Health Applications of Biotechnology, Statistical Definition of 
Biotechnology, at 
http://www.oecd.org/document/42/0,2340,en_2649_34537_1933994_1_1_1_1,00.
html (last visited Nov. 11, 2004). 
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FIGURE 1: BIOTECHNOLOGY PATENTS93 
Panel (a): PCT Applications 
 
 
 
 
 
 
 
 
 
 
 
 
 
Panel (b): European Patent Grants 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
 93. See generally Biological Innovation for Open Society (BIOS) 
[hereinafter BIOS Website], at http://www.bios.net/ (last visited Nov. 15, 2004) 
(on file with authors).  The data supporting this table was originally compiled 
from information on the Center for the Application of Molecular Biology to 
International Agriculture (CAMBIA) Intellectual Property Resource Database, 
at http://www.cambiaip.org/Home/welcome.htm.  The information on the 
CAMBIA Intellectual Property Resource Database was moved to the BIOS 
site.  A copy of the original material remains on file with the authors.  
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The data presented here contrast with recently reported 
analyses of Graff et al., who note drops in patent grants in 
plant biotechnology at the EPO after peaking in 1994-1995.94  
The differences may be due to disparities in the definition of 
plant or agricultural biotechnology.  The Graff et al. definition 
comprises a description of the scope of technologies such as 
genetic engineering of plants, plant genes, and plant breeding 
methods covering a small subset of IPC codes and specific 
technology keywords.95  In contrast, the definition used in this 
paper encompasses broader aspects of plant biotechnology, 
including genetic modification of plants, biocides, organismal or 
enzymic-based methods for preservation of foods, 
microbiological treatment of water and soil, compositions 
containing micro-organisms or enzymes, and processes using 
micro-organisms or enzymes.  The definitional differences are 
highlighted by the order of magnitude difference in the number 
of documents that satisfy the criteria.  For example, in 2000, 
the authors of this article obtained 8,859 PCT applications and 
5,097 patents issued by the European Patent Office (EU 
patents) for inventions concerning agricultural biotechnology 
compared with around 625 PCT and 50 EU patent applications 
and 112 patents for the narrower area of “plant biotechnology” 
reported by Graff et al.96 
The authors of this article have found that the percentage 
of PCT applications in agricultural biotechnology has been on 
the rise.  In 1985, agricultural biotechnology applications were 
4.0 percent of the total submitted.97  By 1990, they were 7.5 
percent of the total, and in 2000 had risen to 9.7 percent of the 
total.98  In 2000, ag-biotech patents granted in EPO were 18.5 
percent of the total granted.99  Clearly further examination of 
patent activity with an eye to the commercial and public good 
consequences encompassing the changing geographical and 
institutional origins of biotechnology innovations on a global 
                                                 
 94. Gregory D. Graff et al., The Public-Private Structure of Intellectual 
Property Ownership in Agricultural Biotechnology, 21 NATURE 
BIOTECHNOLOGY 989, 990 (2003). 
 95. Id. 
 96. Id.  See BIOS Website, supra note 93.   
 97. See id.  
 98. See id.  
 99. See id.  
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scale, and their spillovers or transfer to other countries, will be 
sensitive to the patents included in the source set of documents. 
V.  CROP BIOTECHNOLOGY USE 
The evidence on the worldwide dissemination of 
contemporary, bioengineered crop technologies is usefully 
viewed in the context of the diffusion of the classically bred 
crop varieties that preceded them. 
A.  CLASSICALLY BRED CROP VARIETIES  
1.  Gains in Productivity 
“Worldwide, [around ninety-five] percent of major cereal 
production gains during the past four decades came from 
increased yields, which have more than doubled since 1961.”100  
Increasing yields result from increased use of inputs such as 
agricultural chemicals including fertilizers, herbicides, and 
pesticides, irrigation water, and improved crop varieties.101  In 
the developed world at least, the growth in crop yields began 
picking up pace several hundred years ago.  Looking in detail 
at developments in U.S. wheat varieties since 1800, Alan L. 
Olmstead and Paul W. Rhode, for example, estimated that 
roughly one-half of the U.S. growth in labor productivity 
between 1839 and 1909 was attributable to biological 
innovations.102  Pardey et al. showed that wheat varietal 
change in the United States accelerated during the twentieth 
century: an average of 5.1 commercially successful wheat 
varieties were introduced each year from 1901 to 1970; the rate 
jumped to 21.6 varieties per year during the period 1971 to 
1990.103  Moreover, the creation of these new varieties 
continued to rely heavily on foreign germplasm.104  By the early 
                                                 
 100. C. FORD RUNGE ET AL., ENDING HUNGER IN OUR LIFETIME: FOOD 
SECURITY AND GLOBALIZATION 71 (2003). 
 101. See id. at 69. 
 102. Alan L. Olmstead & Paul W. Rhode, The Red Queen and the Hard 
Reds: Productivity Growth in American Wheat, 1800-1940, 62 J. ECON. HIST. 
929 (2002). 
 103. See PHILIP G. PARDEY ET AL., HIDDEN HARVEST: U.S. BENEFITS FROM 
INTERNATIONAL RESEARCH AID (Int’l. Food Policy Research Inst. Food Policy 
Report, September 1996), available at http://www.ifpri.org/pubs/fps/fps23.htm.  
 104. Id. 
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1990s, one-fifth of the total U.S. wheat acreage and virtually all 
the spring-wheat cropped in California were sown to varieties 
with ancestry derived from the International Maize and Wheat 
Improvement Center (CIMMYT) based in El Batán, Mexico.105  
Pardey et al. estimated that the improved genetic makeup of 
wheat varieties between 1970 and 1993 was worth almost $43 
billion (in 1993 prices) to the United States, or the equivalent of 
10.6 percent of the present value of wheat production during 
this period, and that up to $13.7 billion of that total benefit was 
attributable to varietal spill-ins from CIMMYT alone.106 
There are long lags between committing research and 
development dollars and realizing the returns on that 
investment.  Even in the United States it took decades to build 
up the genetic resource base and train and deploy the scientists 
skilled in classical genetic manipulation techniques before 
reaping the really big dividends during the latter half of the 
twentieth century.107  In the developing world, scientific crop 
breeding lagged well behind.  Beginning in the 1950s and 
1960s, improved varieties became increasingly available to 
farmers and yields rose: wheat yields went from one ton per 
hectare or less in China and India in the mid-1960s to over two 
and a half tons in India, and almost four tons in China, by the 
late 1990s.108  Table 6 shows the rapid spread of modern rice, 
wheat, and maize varieties throughout the developing world.  
Asia embraced these new varieties most rapidly, while adoption 
lagged in Sub-Saharan Africa.  A striking feature of these data, 
however, is the limited uptake of scientifically bred crop 
varieties throughout most of the developing world as late as 
1970.  When virtually all the cropped acreage in rich countries 
was sown to scientifically bred rice and wheat varieties, less 
than one-third of the developing world’s rice acreage and just 
one-fifth of its wheat acreage were planted to modern forms of 
these crops. 
 
 
                                                 
 105. Id.  CIMMYT is the Spanish acronym for the International Maize and 
Wheat Improvement Center. 
 106. Id. 
 107.  See Pardey & Wright, supra note 1.  
 108. See id. 
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TABLE 6: SHARE OF AREA PLANTED TO MODERN VARIETIES OF 
RICE, WHEAT, AND MAIZE109 
 
 Rice   Wheat    Maize  
Regions 1970 1983 1991  1970 1977 1990 1997  1992 1996 
  (percentage of area planted)  
Sub-Saharan 
Africa 4 5 n.a. 5 22 52 66 37 46 
West 
Asia/North 
Africa 0 11 n.a. 5 18 42 66 26 n.a. 
Asia 
(excluding 
China) 12 48 67 42 69 88 93 42 64 
China 77 95 100 n.a. n.a. 70 79 97 99 
Latin 
America 4 28 58 11 24 82 90 49 45 
All 
Developing 
Countries 30 59 74  20 41 70 81  58 62 
 
For these three food staples, much of the crop improvement 
research involved publicly funded and conducted research.  The 
big innovation of the 1960s and 1970s for rice and wheat was 
the development and release of increasing numbers of semi-
dwarf varieties by national and international research agencies 
                                                 
 109. See RUNGE ET AL., supra note 100; DEREK BYERLEE & PIEDAD MOYA, 
CIMMYT, IMPACTS OF INTERNATIONAL WHEAT BREEDING RESEARCH IN THE 
DEVELOPING WORLD 1966-90 (1993); Derek Byerlee, Modern Varieties, 
Productivity, and Sustainability: Recent Experience and Emerging Challenges, 
24 WORLD DEV. 697 (1996); Paul W. Heisey et al., Assessing the Benefits of 
International Wheat Breeding Research: An Overview of the Global Wheat 
Impacts Study, in CIMMYT 1998-1999 WORLD WHEAT FACTS AND TRENDS:  
GLOBAL WHEAT RESEARCH IN A CHANGING WORLD:  CHALLENGES AND 
ACHIEVEMENTS (P.L. Pingali ed. 1999).  For maize, see Michael L. Morris, 
Overview of the World Maize Economy, in MAIZE SEED INDUSTRIES IN 
DEVELOPING COUNTRIES (Michael L. Morris ed., 1998); MICHAEL L. MORRIS, 
IMPACTS OF INTERNATIONAL MAIZE BREEDING RESEARCH IN DEVELOPING 
COUNTRIES, 1966-1998 (2002).  The designation “na” indicates that data is not 
available.  Modern varieties of rice and wheat refer mainly to semi-dwarf 
varieties, for maize it includes hybrid and improved open pollinated varieties. 
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bred using plant material and crop transformation techniques 
that were entirely public domain.110  Almost all the resulting 
improved varieties were made available without personal or 
corporate intellectual property rights.  The public sector 
performed most of the research, and in few jurisdictions were 
intellectual property rights over the varieties themselves or the 
techniques used to transform them even a legal option at that 
time. 
For corn the story is different.  While publicly bred 
varieties were, and remain, a feature of this crop, the private 
sector presence is much more pronounced.111  Hybrid corn 
technologies that took off in the United States in the 1930s and 
later elsewhere offered significant protection for the 
intellectual property embodied in them.112 
This made it possible for breeders to appropriate a larger 
share of varietal benefits than was possible for the self-
replicating forms of varietal transformations featured in rice 
and wheat.113  For hybrid corn varieties, as long as the in-bred 
lines were kept secret and laws were in place in the United 
States and elsewhere to help preserve these trade secrets, the 
cost of imitation was prohibitively large, enabling inventors to 
appropriate significant shares of the benefits stemming from 
their efforts.114 
Table 6 indicates that the developing-country uptake of 
                                                 
 110. Pardey et al., supra note 103. 
 111.  Zvi Griliches, Hybrid Corn: An Explanation in the Economics of 
Technological Change, 25 ECONOMITRICA, 501-522 (1957). 
 112.  Id.  
 113. Hybrid technologies were also pursued for rice and wheat but less 
extensively so.  Mary Knudson and Vernon Ruttan document efforts to develop 
hybrid wheat in the United States.  Mary K Knudson & Vernon W. Ruttan, 
Research and Development of a Biological Innovation: Commercial Hybrid 
Wheat, 21 FOOD RES. INST.  STUD. 45 (1988).  Hybrid rice is grown extensively 
in China, beginning in the mid-1960s.  Since then, the area under hybrid rice 
has increased steadily to about twenty-three percent in 1981 and sixty-one 
percent in 2001.  SHENGGEN FAN ET AL., NATIONAL AND INTERNATIONAL 
AGRICULTURAL RESEARCH AND RURAL POVERTY: THE CASE OF RICE RESEARCH 
IN INDIA AND CHINA 7-8 (Int’l Food Research Inst., Environment and 
Production Technology Division Discussion Paper No. 109, September 2003). 
  Notably, profit potentials were not a contributing factor to the development 
of this technology in China where the research was a government 
undertaking. 
 114. Pardey & Wright, supra note 1. 
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modern maize varieties has also been substantial, but less 
extensive than the move to improved forms of rice and wheat 
worldwide.  This could partly be due to the greater proprietary 
and private sector nature of maize varietal changes, but a 
whole host of other influences could be operative as well.  About 
eighty-six percent of the improved acreage world wide is sown 
to hybrids, the rest to open pollinated varieties. 
2.  Varietal Spillovers 
While the agroecological specificities of much agricultural 
research and development, especially many crop 
biotechnologies, limit the geographical scope of agricultural 
innovations, there is overwhelming evidence that spatial 
spillovers of technologies have played a pivotal part in 
productivity improvements worldwide.  In reviewing the 
economic studies of this phenomenon, Julian Alston concluded 
that interstate or international research and development 
spillovers might account for half or more of the total measured 
productivity growth.115 
Spillovers of crop varietal technologies have flowed in all 
sorts of directions. Looking at the spill-ins to the United States 
of varietal improvement research done at the international 
research centers, specifically the CIMMYT in Mexico and the 
International Rice Research Institute (IRRI) in the Philippines, 
Pardey et al. estimated that, from 1970 to 1993, the U.S. 
economy gained $3.4 billion to $13.7 billion from the use of 
improved wheat varieties developed by CIMMYT depending on 
the benefit attribution methods employed.116  In the same 
twenty-three year period, they found that the U.S. economy 
realized at least thirty million dollars and up to one billion 
dollars through the use of rice varieties developed by the 
IRRI.117 
In more recent research, Pardey et al. quantified the 
benefits from crop improvement research in Brazil and 
attributed them to the Brazilian national agricultural research 
agency (Embrapa), other public and private agencies operating 
                                                 
 115. Julian M. Alston, Spillovers, 46 AUSTRALIAN J. AGRIC. & RESOURCE 
ECON. 315, 338 (2002). 
 116. PARDEY ET AL., supra note 103. 
 117. Id. 
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in Brazil, and spillovers from the Consultative Group on 
International Agricultural Research (CGIAR) and the United 
States.118  They found that, from 1994-2000, sixty-four percent 
of the total benefits from varietal improvement for upland rice 
in Brazil ($1,683 million in 1999) were from non-Embrapa 
sources.119  Likewise, from 1985-2003, sixty-seven percent of 
the total benefits from varietal improvement research for edible 
beans ($677 million in 1999) came from non-Embrapa sources, 
mostly within Brazil, whereas from 1981-2003, seventy-seven 
percent of the total benefits from varietal improvement 
research for soybeans, ($12,473 million in 1999) were due to 
non-Embrapa sources, with twenty-two percent of the benefits 
attributable to spill-ins from the United States.120 
B.  BIOENGINEERED CROP VARIETIES 
Where the crop varieties and bioengineered traits 
embodied in them perform well and are given approval for 
commercial use, the rate of uptake has been rapid, although 
contrary to some claims, not entirely unprecedented, even for 
biological innovations used in agriculture.  For example, Zvi 
Griliches studied the uptake of hybrid corn technologies in the 
United States and showed that there was a zero to fifty percent 
increase in Iowa’s corn acreage sown to hybrid varieties in the 
six years from 1932 to 1938 and reaching ninety percent by 
1940.121  Clive James estimates that 58.7 million hectares were 
planted to bioengineered crops worldwide in 2002, an increase 
from 52.6 million hectares in the previous year and well up on 
the 2.8 million hectares planted in 1996.122 
                                                 
 118. PHILIP G. PARDEY ET AL., ASSESSING AND ATTRIBUTING THE BENEFITS 
FROM VARIETAL IMPROVEMENT RESEARCH IN BRAZIL (Int’l Food Policy 
Research Inst. Research Report No. 136, 2004), available at 
http://www.ifpri.org/.  
 119. Id. 
 120. Id. 
 121. Zvi Griliches, supra note 111, at 502 fig.1. 
 122. See Clive James, Global Review of Commercialized Transgenic Crops: 
2002, (Int’l Service for the Acquisition of Agri- Biotech Applications (ISAAA), 
ISAAA Briefs 2002), available at http://www.isaaa.org.  In 1994 the Flavr-
SavrTM tomato, genetically engineered to delay softening so the tomato could 
ripen on the vine and retain its “fresh picked” flavor, became the first 
bioengineered crop to be grown commercially.  See also, Michele C. Marra et 
al., The Payoffs to Transgenic Field Crops: An Assessment of the Evidence, 5 
AGBIOFORUM 43 (2003), available at 
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Despite this growth, the geographical and technological 
scope of bioengineered crops is still small.  As indicated in 
Figure 2, in 2002, the preponderance of the area under these 
types of crops consisted of bioengineered soybeans, which 
accounted for sixty-two percent of the total bioengineered 
cropping area, while twenty-one percent of the area was sown 
to bioengineered maize, twelve percent to cotton, and five 
percent to canola.123  Just four countries accounted for ninety-
nine percent of the global total in 2002.124  Two-thirds of this 
global total was planted in the United States, twenty-two 
percent in Argentina, six percent in Canada and three percent 
in China.125  Two traits dominate the picture, namely, herbicide 
tolerance mainly in soybeans and canola and insect tolerance 
mainly in corn and cotton, though there are some limited use of 
bioengineered viral resistance in papaya and squash.126 
FIGURE 2: AREA SOWN TO BIOENGINEERED CROPS 
WORLDWIDE127 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
http://www.agbioforum.org./v5n2/v5n2a02-marra.htm. 
 123. James, supra note 122, at 11 tbl.4. 
 124. Id at 7 tbl.3. 
 125. NAT’L AG. STATISTICS SERVICE, U.S. DEP’T OF AGRICULTURE, ACREAGE 
REPORTS (June 2003) [hereinafter NASS Report], available at 
http://usda.mannlib.cornell.edu/reports/nassr/field/pcp-bba/; James, supra note 
122, at 7 tbl.3. 
 126. James, supra note 122, at 11 tbl.4. 
 127.  See id. 
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As indicated in Figure 2, the developing country’s share of 
global bioengineered crop area has grown from fourteen percent 
of the world total in 1997 to about twenty-seven percent in 
2002.  Notably, plantings in just four countries, soybeans in 
Argentina and cotton in China, South Africa, and for the first 
time in 2002, India, account for the lion’s share of the 
developing-country bioengineered acreage.128  Finding 
bioengineered traits that deal successfully with local 
production constraints is one thing, expressing them in specific 
crop varieties that compete well locally against landraces and 
conventionally bred varieties of the same crop, absent the 
bioengineered trait, is another thing.  Not surprisingly, the 
bioengineered traits are being grown in developing-country 
areas that are agroecologically similar to the rich countries for 
which the traits were first developed, and in most cases involve 
the identical crop varieties.  For example, all the officially 
approved Monsanto/DeltaPine bioengineered cotton varieties 
grown in China are the same varieties grown in the United 
States, while most of the bioengineered Chinese varieties are 
based on older DeltaPine varieties introduced into China in the 
1940s and 1950s.129  Likewise the transgenic cotton varieties 
grown in Mexico are from the United States;130 and in South 
Africa, NuCotn 37-B, an American variety, is widely used.131 
This is precisely where the spillover costs are smallest and 
consist mainly of local screening and regulatory approval costs 
along with the costs of marketing the technology.  That is, 
disseminating these particular bioengineered crop varieties 
involves only adaptive or imitative technology development 
costs beyond the initial discovery costs, a much smaller cost 
than inventing entirely new bioengineered traits and 
successfully expressing those traits in locally superior varieties 
of locally important crops. 
The site-specificity of many agricultural biotechnologies 
                                                 
 128. See id. at 5.   
 129. Carl .E. Pray et al., Five Years of Bt Cotton in China—The Benefits 
Continue, 31 PLANT J. 423, 424 (2002). 
 130. Greg S. Traxler, Transgenic Cotton in Mexico: Economic and 
Environmental Impacts, in THE ECONOMIC AND ENVIRONMENTAL IMPACTS OF 
AGBIOTECHNOLOGY: A GLOBAL PERSPECTIVE 183 (2003). 
 131. Colin Thirtle et al., Can GM-Technologies Help the Poor? The Impact 
of Bt Cotton in Makhathini Flats, KwaZulu-Natal, 31 WORLD DEV. 717, 719 
(2003). 
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arises from agroecological aspects, which defines the size of the 
relevant market in a way that is much less common in other 
industrial research and development.  As Julian M. Alston and 
Philip G. Pardey described, one way to think of this is in terms 
of the unit costs of making local research results applicable to 
other locations by adaptive research, which must be added to 
the local research costs.132  Such costs grow with the size of the 
market.133  Economies of size, scale, and scope in research 
mean that unit costs fall with size of the research and 
development enterprise, but these economies must be traded off 
against the diseconomies of distance and adapting site-specific 
results such as the costs of “transporting” the research results 
to economically “more distant” locations.134  Thus, as the size of 
the research enterprise increases, unit costs are likely to 
decline at first because economies of size are relatively 
important, but will eventually rise as the costs of economic 
distance become ever-more important. 
Given that the United States dominates the world totals, 
its trends are worth scrutinizing.  Ranked in terms of total 
acreage, the world and U.S. crop relativities for 2002 are the 
same—soybeans dominate, followed by corn and cotton.135  
However, the intensity of use of bioengineered versus 
classically bred crops differs between the Unites States and the 
rest of the world.  As indicated in Figure 3, the United States 
uniformly makes more intensive use of bioengineered crops 
than the rest of the world.  While seventy-seven percent of the 
U.S. canola crop was sown to bioengineered varieties in 2002, 
the corresponding rest-of-world share was twelve percent.  
Likewise, bioengineered soybeans covered seventy-one percent 
of the U.S. soybean acreage and only twenty-eight percent of 
                                                 
 132. Julian M. Alston, & Philip G. Pardey, The Economics of Agricultural 
R&D Policy, in PAYING FOR AGRICULTURAL PRODUCTIVITY (Julian M. Alston 
et al. eds., 1999). 
 133. A close analogy can be drawn with spatial market models of food 
processing in which processing costs fall with throughput but input and output 
transportation costs rise with throughput so that when the two elements of 
costs are combined, a U-shaped average cost function is derived. See, e.g., 
Richard J. Sexton, Imperfect Competition in Agricultural Markets and the Role 
of Cooperatives: A Spatial Analysis, 72 AM. J. AGRIC. ECON. 709, 714 fig.1 
(1990). 
 134. See Alston & Pardey, supra note 132. 
 135. NASS Report, supra note 125.   
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the rest-of-world soybean area.136  For cotton the corresponding 
shares were seventy-one percent for the United States and 
eleven percent for the rest of the world; for corn it was thirty-
four percent for the United States and 1.4 percent elsewhere.137  
This reflects both technology and market realities.  While the 
dominant bioengineered traits such as those that target mainly 
budworm/boll weevil complexes in cotton and European stem 
borers in corn, as well as Roundup® and Liberty Link® 
resistance in soybeans and canola have yield-enhancing or cost-
reducing consequences for rest-of-world farmers, they are 
especially consequential for United States producers.  In 
addition, given their earlier regulatory approval in the United 
States, these traits are now incorporated into a number of 
locally optimized crop varieties. 
FIGURE 3: BIOENGINEERED CROPPING INTENSITIES – UNITED 
STATES VS REST-OF-THE-WORLD, 2002138 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
 136. See Marra, supra note 122, at 43 (“In some U.S. states, the share of 
2002 soybean acres planted to [Roundup Ready®] soybeans is approaching 
[ninety percent]”), available at http://www.agbioforum.org./v5n2/v5n2a02-
marra.htm. 
 137.  See James, supra note 122; NASS Report, supra note 125.  
 138. Data represent share of respective crop acreage in each region sown to 
bioengineered varieties.  See James, supra note 122, at 11 tbl.4; NASS Report, 
supra note 125. 
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VI.  SUMMING UP 
This paper demonstrates that the preponderance of 
research conducted on bioengineered crops is carried out in rich 
countries where the overwhelmingly large share of 
biotechnology acreage is still to be found, and much of the 
product development work is performed by private firms.  
Moreover, most of the bioengineered traits and the specific crop 
varieties that are planted in developing countries are spillovers 
from, or adaptive modifications of, rich-country research.  Only 
when we achieve a reasonable rate of inventor appropriability 
of the returns to the technologies that are applicable in less-
developed countries, combined with an economic infrastructure 
that facilitates adoption of those technologies, can we expect a 
significant private-sector role to emerge in the poorer parts of 
the world. 
This paper also draws attention to the comparatively low 
rates of investment in public agricultural research and 
development in developing countries, where government 
revenues may be comparatively expensive due to lower tax 
revenues, or have a comparatively high opportunity cost.139  
Many less-developed countries are characterized by under-
investment in a host of other public goods, such as 
transportation and communications infrastructure, schools, 
hospitals, and the like, as well as agricultural science.  These 
other activities, like agricultural science, might also have high 
social rates of return.140  In many less-developed countries, 
where agriculture represents a much greater share of the total 
economic activity, and where per capita incomes are much 
lower, a meaningful investment in public agricultural research 
might have a much more appreciable impact on individual 
citizens.  The problem, however, is that this burden is felt now, 
while the payoff it promises may take a long time to come, and 
will be much less visible when it does. 
Even among the rich countries of the world, most have not 
had very substantial private or public agricultural science 
industries.  Why, then, should we expect the poorest countries 
                                                 
 139. Julian M. Alston & Philip G. Pardey, Developing Country Perspectives 
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R&D POLICY IN THE DEVELOPING WORLD (forthcoming 2005). 
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of the world to be more like the richest of the rich in this 
regard?141  The lion’s share of the public, as well as private, 
investment in agricultural science has been undertaken by a 
small number of countries; generally, these countries have 
undertaken the lion’s share of scientific research as well.142  An 
important consideration is economies of size, scale, and scope in 
research, which influence the optimal size and portfolio of a 
given research institution.  In some cases the “optimal” 
institution may efficiently provide research for a state or region 
within a nation, but for some kinds of research the efficient 
scale of institutions may be too great for an individual nation.  
Many nations may be too small to achieve an efficient scale in 
much if any of the relevant elements of their interests’ in crop 
biotechnology research, except perhaps in certain types of 
adaptive research. 
Historically, there have been large spillovers of improved 
varieties and the technology and know-how embodied in them 
from one country to another.  However, we cannot presume 
that the rich countries of the world will play the same roles as 
in the past.143  In particular, countries that in the past relied on 
technological spillovers from the North may no longer have 
that luxury available to them in the same ways or to the same 
extent.144  This change can be seen as involving three elements.  
First, the types of technologies being developed in the rich 
countries may no longer be as readily applicable to less-
developed countries as they were in the past.  The agenda in 
richer countries is shifting away from areas like yield 
improvement in major crops to other crop characteristics and 
even to non-agricultural issues.145  Second, the private presence 
in rich country agricultural research and development has 
increased and many biotech companies are not as interested in 
developing technologies for many less-developed country 
applications.  Even where they have such technologies 
                                                 
 141. See PARDEY & BIENTEMA, supra note 5, at 13 (noting the geographical 
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available, often they are not interested in pursuing potential 
markets in less developed countries.146  And third, those 
technologies that are applicable and available are likely to 
require more substantial local development and adaptation, 
calling for more sophisticated and extensive forms of scientific 
research and development than in the past.  For instance, more 
advanced skills in modern biotechnology or conventional 
breeding may be required to take advantage of enabling 
technologies or simply to make use of less-finished lines that 
require additional work to tailor them to local production 
environments.147  In short, different approaches may have to be 
devised to make it possible for less-developed countries to 
achieve equivalent access to technological potentials generated 
by rich countries.  In many instances, less-developed countries 
may have to extend their own research and development efforts 
to more fundamental areas of the science. 
Some argue that strengthening intellectual property 
regimes in poorer countries is one way of stimulating 
investments in developing-country research and development 
as well as efforts to commercialize crop technologies developed 
elsewhere.148  Others argue that the number and breadth of 
patents, plant breeders’ rights, and other forms of intellectual 
property hinders the research and development required to 
tackle food security concerns of poor countries.149  Binenbaum 
et al. studied the situation for fifteen staple food crops of the 
world and concluded there was undue concern that intellectual 
property rights were currently limiting the freedom to operate 
for research on developing-country food staples.150  The 
Binenbaum et al. study reinforced the intellectual property 
evidence assembled for some key enabling technologies used in 
agriculture: intellectual property rights concerning crop 
biotechnologies are overwhelmingly concentrated in rich-
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country jurisdictions, meaning poor-country research can 
proceed largely unencumbered by any intellectual property 
restraints.151  Binenbaum et al. also showed that bilateral trade 
in food staples from poor- to rich-countries in which intellectual 
property was presumptively in force was meager and limited to 
just a few crops from a few poor countries,152 meaning the 
results of this research can be disseminated and used with few 
if any intellectual property impediments if the intent is to feed 
and clothe poor people in poor countries. 
As things stand today, the constraints to conducting 
modern crop biotechnology research in developing countries 
appear to lie largely beyond intellectual property concerns.  
Market considerations limit substantial private interests for 
many crops in many developing countries, and the intensity of 
public investments is generally low for reasons that do not 
seem likely to change soon.153  Intellectual property rights may 
have a role to play in stimulating efforts to commercialize crops 
in developing countries, especially helping to harness spill-in 
technologies developed elsewhere, but, at least in the nearer 
term, they will be no substitute for rich and poor country 
governments alike reinvesting in the research and development 
required to maintain and continue adding to the crop yields 
necessary in the decades ahead. 
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